News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Read moreUltimate Guide: Everything You Need to Know About Industry 4.0 Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories Machine Learning News Software Development OCC Enhances Operational Efficiency with AWS GenAI Solutions Data Center News Vector Capital Originates $50 Million Loan for Sylvan’s Strategic Combination with Andy J. Egan Co., Inc. News Qlik Delivers Secure, Open Access to Trusted Data in Any Tool News Soldo’s 2025 Winter Launch Helps Finance Keep Spend in Flow News G42 Receives U.S. Approval for Advanced AI Chip Exports, Enabling Full-Scale Deployment of Trusted AI Infrastructure News Cloudera Reinforces Commitment to Saudi Vision 2030 with plans to launch its data and AI platform on the AWS Saudi Arabia Region